Tech-enabled, full-service CAP-accredited and CLIA-certified lab with a mobile platform delivering most test results in under 30 minutes.

Seed sees onsite diagnostics as a transformational shift in care delivery and workflow efficiency.

Seed Healthcare Fund invested 1M* in SPV in 2024 and Genalyte will have exposure through commercialization efforts of Seed.

*Amount TBD.